Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

Plasma cell-free tumor DNA, or circulating tumor DNA (ctDNA), from liquid biopsy is a potential source of tumor genetic material, in the absence of tissue biopsy, for EGFR testing. Our validation study reiterates the clinical utility of ctDNA next generation sequencing (NGS) for EGFR mutation testin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Lung Cancer (Auckl)
Autori principali: Veldore, Vidya H, Choughule, Anuradha, Routhu, Tejaswi, Mandloi, Nitin, Noronha, Vanita, Joshi, Amit, Dutt, Amit, Gupta, Ravi, Vedam, Ramprasad, Prabhash, Kumar
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2018
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5757203/
https://ncbi.nlm.nih.gov/pubmed/29379323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S147841
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi